Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02911831 · ClinicalTrials.gov registry record · Early Phase 1
IV Tranexamic Acid Prior to Hysterectomy
A Early Phase 1 study, sponsored by Northwestern University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 71
- Enrollment target
NCT02911831 is a Early Phase 1 study that has completed, run by Northwestern University. The registered enrollment target is 71 participants.
The verdict
NCT02911831, a Early Phase 1 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 71 participants
- Enrollment target
Study Summary
The objective of this study is to determine the effect of 1g of IV tranexamic acid given within 1 hour pre-operatively on intraoperative blood loss at time of hysterectomy.
Interventions
- DRUG Tranexamic Acid
- DRUG Sodium Chloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2016-11 |
| Est. Completion | 2022-04 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02911831
The ClinicalTrials.gov registry entry for NCT02911831 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tranexamic Acid is the first listed.
NCT02911831 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02911831 about?
NCT02911831 is a clinical study titled "IV Tranexamic Acid Prior to Hysterectomy". The objective of this study is to determine the effect of 1g of IV tranexamic acid given within 1 hour pre-operatively on intraoperative blood loss at time of hysterectomy.
What is the current status of trial NCT02911831?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 71 participants. The study started on 2016-11. Estimated completion is 2022-04.
What interventions are being tested in trial NCT02911831?
The interventions under investigation include: Tranexamic Acid (DRUG), Sodium Chloride (DRUG).
Who is sponsoring clinical trial NCT02911831?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.